|
 The health agency will amend the emergency use authorizations for
the two vaccines as soon as Thursday to allow immunocompromised
people to get an additional dose, the report said, citing people
familiar with the matter.
The agency is closely monitoring data as it becomes available from
studies administering an additional dose of the authorized COVID-19
vaccines to immunocompromised individuals, FDA spokesperson Abby
Capobianco said in a statement.
"The FDA, along with the CDC, is evaluating potential options on
this issue, and will share information in the near future,"
Capobianco said.
[to top of second column] |
 A U.S. Centers for Disease
Control and Prevention (CDC) advisory panel will
meet on Friday to review data on booster doses
in immune compromised individuals. While there
is no vote listed on the draft agenda for the
meeting, the Federal Register entry said a
recommendation vote is scheduled.
(Reporting by Mrinalika Roy in Bengaluru;
Editing by Maju Samuel)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
